Alagille Syndrome

People with Alagille Syndrome are asked to participate in a research study being conducted by the NYU Langone Fink Children’s Ambulatory Care Center.

You may be eligible to participate in this study if you:

• Have signed or willing to sign informed consent and assent as appropriate
• Have completed 104-week Treatment Period of Study A4250-012

You may not participate in this study if you:

• Have decompensated liver disease, history or presence of clinically significant ascites, variceal hemorrhage, and/or encephalopathy
• Have any clinically important conditions or abnormalities
• Have known hypersensitivity to any components of study product

Contact Information
Neha Ogale, Study Coordinator